ADVERTISEMENTs
.png)
Rep. Ami Bera introduces Bipartisan GAIN Act to address Alzheimer’s disease globally
With the introduction of the GAIN Act, lawmakers aim to position the United States at the forefront of the global fight against Alzheimer’s, emphasizing the critical role of international partnerships in tackling this growing health crisis.
Ami Bera / Image- Wikipedia
Indian American Representative Ami Bera, (CA-06), introduced the bipartisan Global Alzheimer’s Initiative Now (GAIN) Act, underscoring the United States’ commitment to addressing Alzheimer’s disease and dementia through international collaboration.
The bill, co-sponsored by Reps. Brian Fitzpatrick (R-PA-01) and Young Kim (R-CA-40), seeks to bolster global research, prevention, and care by authorizing U.S. participation in the Davos Alzheimer’s Collaborative (DAC), a public-private-patient partnership which coordinates efforts at more than 135 global sites to enhance brain health, improve early detection and treatment, and advance inclusive research initiatives.
The GAIN act positions the United States as a leader in combating Alzheimer’s, which currently affects nearly 60 million people worldwide, a number projected to exceed 150 million by 2050, an official statement from his office said.
“Alzheimer’s disease is a global challenge that demands a global response,” said Rep. Bera. “The GAIN Act ensures that the United States leads the charge in building partnerships that accelerate research, improve care, and support families everywhere. By strengthening global cooperation, we can achieve more than any single nation can alone.”
Rep. Fitzpatrick emphasized the urgency of the crisis, calling for immediate action. “The alarming rate at which Alzheimer’s is inflicting our population requires swift and decisive action. This legislation positions America to spearhead life-saving research and sustainable care worldwide,” he said.
Rep. Kim, reflecting on the impact in her district and beyond, stressed the need for dedicated resources. “Alzheimer’s disease is the third leading cause of death in older adults in Orange County and the seventh leading cause of death worldwide,” she said. “The GAIN Act ensures the United States leads the global effort to combat Alzheimer’s disease and other forms of dementia head-on.”
The legislation emphasizes international collaboration to develop innovative diagnostics, treatments, and care models, with a focus on low- and middle-income countries, which account for 70 percent of global Alzheimer’s cases. It seeks to align U.S. investments with multilateral initiatives to foster innovation and ensure equitable burden-sharing. The bill also highlights the need for sustainable healthcare systems and caregiver support, as well as advancing prevention strategies to reduce the prevalence of Alzheimer’s.
George Vradenburg, Chairman of UsAgainstAlzheimer’s and founder of the Global CEO Initiative on Alzheimer’s Disease, commended the bipartisan effort. “This legislation recognizes the urgent need for a global response to Alzheimer’s that brings together governments and the private sector to advance prevention, diagnosis, and treatment,” he said. “U.S. leadership will prove critical in turning the tide on Alzheimer’s over the coming decades.”
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpg)
.jpg)
.jpg)
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login